Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Although the federal government has introduced a voluntary programme to lower prices for GLP-1 weight-loss medications, many U.S. states are reluctant to participate, leaving coverage gaps for Medicaid patients seeking obesity treatment. For Medicaid patients waiting on coverage for GLP-1…
Abbott has received FDA clearance for its Libre Duo 10 Day system, a pioneering wearable that continuously monitors both glucose and ketone levels, aiming to improve early detection of diabetic ketoacidosis for people with diabetes aged two and above. Abbott…
A new study presented at the ALS Nexus conference reveals that individuals with long-standing diabetes, particularly those treated with insulin, may have a significantly reduced risk of developing amyotrophic lateral sclerosis, shedding light on potential metabolic influences on the disease.…
Peptron has filed an investigational new drug application for PT403, a once-monthly semaglutide injection designed to improve obesity treatment adherence, marking a significant step in its development using the SmartDepot sustained-release technology. Peptron has moved a step closer to testing…
Enveda reports positive early safety data for ENV-308, an experimental oral drug inspired by exercise-induced molecule Lac-Phe, as it advances toward larger studies to assess its potential in weight regain prevention after GLP-1 therapy. Enveda has reported encouraging first human…
New insights into neonatal diabetes reveal that remission is often temporary, with about half of affected children experiencing a relapse during adolescence or early adulthood, highlighting the importance of ongoing monitoring and genetic testing. Neonatal diabetes is a rare condition…
Novo Nordisk sues Eli Lilly over misleading advertising comparing dosages of GLP-1 weight-loss drugs, raising concerns about how clinical data is presented to consumers amidst ongoing regulatory scrutiny. Novo Nordisk’s lawsuit against Eli Lilly is turning a technical dispute over…
New research presented at the European Association for the Study of Diabetes 2026 meeting reveals a nearly tenfold increase in type 2 diabetes among Colorado teenagers over two decades, underscoring the critical importance of early diagnosis and preventative measures. New…
South Korean biotech Hanmi Pharm has entered a multibillion-dollar licensing agreement with Genentech to co-develop a promising obesity drug candidate, marking a significant milestone in personalised obesity therapy. Hanmi Pharm has struck an exclusive licensing deal with Genentech for HM17321,…
Research indicates that the triglyceride-glucose (TyG) index, a simple blood test tool, could help identify adolescents at risk of developing hypertension, heralding a shift in early cardiovascular risk screening for teens. A routine blood calculation is gaining traction as a…
Experts in Belgium call for expanded reimbursement for GLP-1 medications, citing their potential to prevent serious health conditions and improve patients’ quality of life, as current criteria may be too restrictive amid rising obesity rates. Belgium is facing a growing…
Research presented at the European Association for the Study of Diabetes indicates that certain inherited insulin receptor mutations could be associated with a healthier cardiometabolic profile, challenging traditional notions of insulin resistance as solely harmful. A rare inherited form of…
